Octenilin is a wound cleansing and debridement support range designed to gently cleanse acute and chronic wounds while helping maintain a moist, healing-friendly environment. Formulated to support effective removal of biofilm, debris, and wound contaminants, Octenilin products are intended for use without damaging healthy tissue or delaying natural healing processes.
The range is widely used in hospitals, wound care clinics, and community healthcare settings for the management of chronic wounds such as pressure injuries, diabetic foot ulcers, and venous leg ulcers, as well as acute wounds including surgical sites and traumatic injuries. Its gentle, tissue-friendly formulation makes it suitable for repeated use during ongoing wound care and dressing changes.
Octenilin is particularly valued for its ability to support wound bed preparation by helping soften and loosen necrotic tissue and biofilm, making cleansing and subsequent treatment more effective. It is commonly used as part of a broader wound management protocol to improve overall wound hygiene and healing outcomes.
The Octenilin range is developed by Schülke & Mayr, a global specialist in infection control, antisepsis, and wound care technologies.
The portfolio includes products such as Octenilin Wound Irrigation Solution and Octenilin Wound Gel, designed to work together or independently depending on clinical needs.
Overall, Octenilin is trusted by healthcare professionals for its gentle yet effective cleansing action, helping support wound bed preparation and promote a cleaner, more stable environment for healing.